
Article 1 
Trans-resveratrol as specified in the Annex to this Decision may be placed on the market in the Union as a novel food ingredient to be used in food supplements in capsule or tablet form intended for adult population only with a maximum dose of 150 mg per day without prejudice to the provisions of Directive 2002/46/EC.
Article 2 

1. The designation of trans-resveratrol authorised by this Decision on the labelling of the foodstuffs containing it shall be ‘trans-resveratrol’.
2. The labelling of food supplements containing trans-resveratrol shall bear a statement that people using medicines should only consume the product under medical supervision.
Article 3 
This Decision is addressed to DSM Nutritional Products Ltd, Heanor Gate Ind. Est. Heanor, Derbyshire, United Kingdom.
Done at Brussels, 19 July 2016.
For the Commission
Vytenis ANDRIUKAITIS
Member of the Commission
ANNEX

Chemical name 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol
Chemical formula C14H12O3
Molecular weight 228,25 Da
CAS No 501-36-0
Description:Trans-resveratrol is off-white to beige crystals.


Trans-resveratrol Not less than 99 %
Total by-products (related substances) Not more than 0,5 %
Any single related substance Not more than 0,1 %
Lead Not more than 1 ppm
Mercury Not more than 0,1 ppm
Cadmium Not more than 0,5 ppm
Arsenic Not more than 1 ppm
Loss on drying Not more than 0,5 %
Sulphated ash Not more than 0,1 %
Diisopropylamine Not more than 50 mg/kg
